ArticlePloS one2026
Modifiable psychosocial risk factors for depression among cancer survivors in the United States.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Depression is highly prevalent among cancer survivors and contributes to poorer quality of life, reduced treatment adherence, and increased morbidity. Functional limitations, loneliness, and inadequate social and emotional support are important psychosocial factors associated with self-reported lifetime diagnosis of major depressive disorder among cancer survivors. Using a cross-sectional study design, this study examined the independent associations of functional limitations, loneliness, and social/emotional support with a self-reported lifetime diagnosis of major depressive disorder among a large sample of U.S. cancer survivors. Data were drawn from the 2023 and 2024 Behavioral Risk Factor Surveillance System. The analytic sample included 70,620 adult cancer survivors (56.3% female) with depression as the outcome variable. Functional limitations, loneliness, and social/emotional support were primary explanatory variables. Multivariable logistic regression models estimated adjusted odds ratios (AORs) and 95% confidence intervals (CIs), controlling for demographic, socioeconomic, and health-related covariates. Overall, 21.8% of cancer survivors reported depression. In the fully adjusted models, loneliness (AOR = 2.72, 95% CI: 2.44-3.03), functional limitations (AOR = 2.05, 95% CI: 1.81-2.31), and lack of social/emotional support (AOR = 1.43, 95% CI: 1.27-1.62) were independently associated with higher odds of depression. Female sex, low income, cost-related forgone medical care, poor self-rated health, obesity, and current/former smoking were also significantly negatively associated with depression, while physical activity was protective. We found that functional limitations, loneliness, and inadequate social support are robust and independent associated factors of depression among cancer survivors. Screening and interventions targeting these psychosocial factors may improve mental health outcomes and enhance overall survivorship care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.